Lipid Metabolism Disorder and Renal Fibrosis
Since the lipid nephrotoxicity hypothesis was proposed in 1982, increasing evidence has supported the hypothesis that lipid abnormalities contributed to the progression of glomerulosclerosis. In this chapter, we will discuss the general promises of the original hypothesis, focusing especially on the role of lipids and metabolic inflammation accompanying CKD in renal fibrosis and potential new strategies of prevention.
KeywordsLipids Inflammation Glomerular atherosclerosis Tubulo-interstitial diseases Statin
“Lipid Nephrotoxicity: New Concept for an Old Disease” was reported by our group in Dyslipidemias in Kidney Disease (Ruan et al. 2014). The related contents are reused with permission.
- Clark JS, Carter AJ, Dixit M, Arany I (2016) Simvastatin inhibits epithelial-to-mesenchymal transition through induction of HO-1 in cultured renal proximal tubule cells. Vivo 30:407–411Google Scholar
- Ginsberg HN, Le NA, Goldberg IJ, Gibson JC, Rubinstein A et al (1986) Apolipoprotein B metabolism in subjects with deficiency of apolipoproteins CIII and AI. Evidence that apolipoprotein CIII inhibits catabolism of triglyceride-rich lipoproteins by lipoprotein lipase in vivo. J Clin Invest 78:1287–1295PubMedPubMedCentralCrossRefGoogle Scholar
- Ruggiero C, Elks CM, Kruger C, Cleland E, Addison K et al (2014) Albumin-bound fatty acids but not albumin itself alter redox balance in tubular epithelial cells and induce a peroxide-mediated redox-sensitive apoptosis. Am J Physiol Renal Physiol 306:F896–F906PubMedPubMedCentralCrossRefGoogle Scholar
- Vaziri ND, Moradi H, Pahl MV, Fogelman AM, Navab M (2009) In vitro stimulation of HDL anti-inflammatory activity and inhibition of LDL pro-inflammatory activity in the plasma of patients with end-stage renal disease by an apoA-1 mimetic peptide. Kidney Int 76:437–444PubMedPubMedCentralCrossRefGoogle Scholar